Literature DB >> 33316725

Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy.

Arianna Scartezzini1, Fabio Tateo2, Paola Perini1, Luca Benacchio3, Mario Ermani1, Antonio Ferro4, Morena Cadaldini5, Maria Grazia Piccinno6, Luisella Colledan7, Nicoletta Freddi8, Paolo Gallo1, Marco Puthenparampil9.   

Abstract

BACKGROUND: Fifty years of epidemiological survey and intra-regional differences in prevalence suggest that environmental factors may be associated with increased multiple sclerosis (MS) risk in Northern Italy. Based on the findings of a previous study carried out in the highly polluted Padan Plain, we further explored the relationship between PM2.5 levels and MS prevalence by comparing bordering areas characterized by quite different environmental conditions, namely the Municipality of Padua and the special protected zone (SPZ) of the Euganean Hills Regional Park, located 15 km from the City.
METHODS: Three territories were identified; 1) the SPZ, extending over an area of 15.096 hectares and having a total population of 23,980 inhabitants, 2) the urban area of Padua, with a total population of 210,440 inhabitants and repeatedly recognized by the European Invironmental Agency as one of the most polluted Cities of Europe, 3) the Intermediate Zone (IZ), i.e., the area in between the previous two, including part of the urban territories of eight villages adjacent to the SPZ. Demographic and socio-economical data were obtained from official government sources (www.istat.it and www.regione.veneto.it). All Italian MS patients residing in these three areas on December 31, 2018, were registered. PM2.5 concentrations (annual average 1998-2018, μg/m3) were measured by satellite. The correlation between PM2.5 concentrations and MS prevalence was analysed.
RESULTS: MS prevalence was significantly higher in Padua City (265/100.000) compared to both the SPZ of the Euganean Hills Park (160/100,000; p < 0.0001) and the IZ (194.4/100,000). Prevalence strongly associated with the annual average concentration of PM2.5 (r = 0.89 p < 0.00001).
CONCLUSION: In the Province of Padua, one of the most polluted areas of Europe, MS prevalence is strongly associated with PM2.5 exposure. Our findings suggest that air pollutants may be one of the possible environmental risk factors for MS in the Veneto Region of Italy.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Epidemiology; Multiple Sclerosis; PM2.5; Prevalence; Risk factors

Mesh:

Substances:

Year:  2020        PMID: 33316725     DOI: 10.1016/j.msard.2020.102677

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Traffic-generated air pollution - Exposure mediated expression of factors associated with demyelination in a female apolipoprotein E-/- mouse model.

Authors:  Anna Adivi; JoAnn Lucero; Nicholas Simpson; Jacob D McDonald; Amie K Lund
Journal:  Neurotoxicol Teratol       Date:  2022-01-10       Impact factor: 3.763

Review 2.  Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study.

Authors:  Mohammad Javad Mohammadi; Kourosh Zarea; Nasser Hatamzadeh; Arash Salahshouri; Asaad Sharhani
Journal:  Front Public Health       Date:  2022-07-06

3.  Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia.

Authors:  Pardis Zarifkar; Costanza Peinkhofer; Michael E Benros; Daniel Kondziella
Journal:  Front Neurol       Date:  2022-06-23       Impact factor: 4.086

4.  Effects of environmental parameters and their interactions on the spreading of SARS-CoV-2 in North Italy under different social restrictions. A new approach based on multivariate analysis.

Authors:  Fabio Tateo; Sirio Fiorino; Luca Peruzzo; Maddalena Zippi; Dario De Biase; Federico Lari; Dora Melucci
Journal:  Environ Res       Date:  2022-02-10       Impact factor: 8.431

Review 5.  Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors.

Authors:  M Puthenparampil; P Perini; R Bergamaschi; M Capobianco; M Filippi; P Gallo
Journal:  J Neurol       Date:  2021-09-27       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.